James Sapirstein - Jan 3, 2022 Form 4 Insider Report for First Wave BioPharma, Inc. (FWBI)

Role
PRES, CEO & CHAIRMAN OF BOARD, Director
Signature
/s/ James Sapirstein
Stock symbol
FWBI
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 08:07 PM
Previous filing
Jul 2, 2021
Next filing
Feb 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +150K $0.00 150K Jan 3, 2022 Common stock, par value $0.0001 per share 150K $1.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 36 equal monthly installments over a term of three (3) years beginning on the date of grant, conditioned on Mr. Sapirstein's continued employment by First Wave BioPharma, Inc. on the applicable vesting date.